~ OXIS International, Inc. (OTCQB: OXIS) –OXIS develops, commercializes, and addresses existing clinical shortcomings of related products with innovative drugs containing therapeutic molecules such as cannabinoids, which are focused on several cancer indicators. Utilizing the powerful compounds found in cannabinoid-producing plants, OXIS will produce a platform of synthesized cannabinoid agents that target the treatment of cancer cells in multiple areas.

http://www.otcmarkets.com/stock/OXIS/news?id=95930